31. Newman R.B., Goldenberg R.L., Iams J.D., Meis P.J., Mercer B.M., Moawad A.H. et al. Preterm prediction study: comparison of the cervical score and Bishop score for prediction of spontaneous preterm delivery. Obstet Gynecol. 2008; 112(3): 508–15.
32. Alfrevic Z., Allen-Coward H., Molina F., Vinuesa C.P., Nicolaides K. Targeted therapy for threatened preterm labor based on sonographic measurement of the cervical length: a randomized controlled trial. Ultrasound Obstet Gynecol. 2007; 29(1): 47–50.
33. Berghella V., Palacio M., Ness A., Alfrevic Z., Nicolaides K.H., Saccone G. Cervical length screening for prevention of preterm birth in singleton pregnancy with threatened preterm labor: systematic review and meta-analysis of randomized controlled trials using individual patient-level data. Ultrasound Obstet Gynecol. 2017; 49(3): 322–9.
34. Приказ Минздрава РФ от 20.10.2020 г. № 1130н «Об утверждении Порядка оказания медицинской помощи по профилю «акушерство и гинекология» http://sudact.ru/law/prikaz-minzdrava-rossii-ot-20102020-n-1130n/prilozhenie-n-1/.
35. Norman J.E., Marlow N., Messow C.-M., Shennan A., Bennett P.R., Thornton S. et al. Does progesterone prophylaxis to prevent preterm labour improve outcome? A randomised double blind placebo-controlled trial (OPPTIMUM). Health Technol Assess. 2018; 22(35): 1–304.
36. Medley N., Poljak B., Mammarella S., Alfrevic Z. Clinical guidelines for prevention and management of preterm birth: a systematic review. BJOG. 2018; 125(11): 1361–9.
37. Ting H.-S., Chin P.-S., Yeo G.S.H., Kwek K. Comparison of bedside test kits for prediction of preterm delivery: phosphorylated insulin-like growth factor binding protein-1 (pIGFBP-1) test and fetal fibronectin test. Ann Acad Med Singapore. 2007; 36(6): 399–402.
38. Сorabian P. The ACTIM PARTUS versus THE TLIIQ ® SYSTEM as rapid response tests to aid in diagnosing preterm labour in symptomatic women. In: Institute of Health Economics, Canada. 2008.
39. Fuchs F., Houllier M., Leparco, Guyot A., Senat M.V., Fernandez H. Performance of cervical phIGFBP-1 test alone or combined with short cervical length to predict spontaneous preterm birth in symptomatic women. Sci. Rep. 2017; 7(1): 10856.
40. Khambay H., Bolt L.A., Chandiramani M., De Greeff A., Filmer J.E., Shennan A.H. The Actim Partus test to predict pre-term birth in asymptomatic high-risk women. J. Obstet. Gynaecol. 2012; 32(2): 132–4.
41. Petrunin D.D., Gryaznova I.M., Petrunina Y.A. et al. Comparative immunochemical and physicochemical characteristics of chronicα1 and α2-microglobulins of the human placenta. Bull. Exp. Biol. Med. 1978. 85, doi: 10.1007/BF00806400.
42. Fuchs B.B., Boltovskaya M.N., Zaraiskii E.I., Nazimova S.V. Monoclonal antibodies against placental alpha-1-microglobulin (PAMG-1) International Journal of Immunopharmacology. 1991. 13(6), 793.
43. Sukchaya K., Phupong V. Comparative study of positive rate of placental alpha-microglobulin-1 test in pre-term pregnant women with and without uterine contraction. Journal of Obstetrics and Gynaecology. 2013. 33, 566–568. DOI: 10.3109/01443615.2013.807786.
44. Saul W. Rosen. New placental proteins: Chemistry, physiology and clinical use. Placenta. 1986. 7(6), 575–594.
45. Lee S.M., Romero R., Park J.W. et al. The clinical significance of a positive Amnisure test (TM) in women with preterm labour and intact membranes. J. Matern. Fetal Neonatal Med. 2012. 25 (9): 1690–1698.
46. Фаткуллин И.Ф., Ахметгалиев А.Р., Мунавирова А.А., Фаткуллин Ф.И. Преимущества применения диагностической экспресс-тест-системы для определения плацентарного α-микроглобулина-1 в цервикальном содержимом для идентификации начавшихся/угрожающих преждевременных родов // Акушерство и гинекология. 2018; 1: 62–8. https://dx.doi.org/10.18565/aig.2018.1.62-68.
47. Lotfi G., Faraz S., Nasir R., Somini S., Abdeldayem R.M., Koratkar R. et al. Comparison of the effectiveness of a PAMG-1 test and standard clinical assessment in the prediction of preterm birth and reduction of unnecessary hospital admissions. J. Matern. Fetal Neonatal Med. 2017; October 26: 1–5.
48. Melchor J.C., Navas H., Marcos M., Iza A., de Diego M., Rando D. et al. Retrospective cohort study of PAMG-1 and fetal fibronectin test performance in assessing spontaneous preterm birth risk in symptomatic women attending an emergency obstetrical unit. Ultrasound Obstet. Gynecol. 2017; Aug 29. Available at: https://www.ncbi.nlm.nih.gov.
49. Hadzi-Lega M., Maier J.T., Helmer H., Hellmeyer L., Markova A.D., Poposka A. Comparison of PAMG-1 and phIGFBP-1 tests for the prediction of preterm delivery in patients with preterm labor. Open J. Obstet. Gynecol. 2017; 7(3): 358–68.
50. Ravi M., Beljorie M., El Masry K. Evaluation of the quantitative fetal fibronectin test and PAMG-1 test for the prediction of spontaneous preterm birth in patients with signs and symptoms suggestive of preterm labor. J. Matern. Fetal Neonatal Med. 2018; May 28: 1–6.
51. Melchor J.C., Khalil A., Wing D., Schleussner E., Surbek D. Prediction of preterm delivery in symptomatic women using placental alpha-microglobulin-1, fetal fibronectin and phosphorylated insulin-like growth factor-binding protein-1 tests: systematic review and meta-analysis stratified by risk. Ultrasound Obstet. Gynecol. 2018; Jun 19. DOI: 10.1002/uog.19119.